Will the Parkinson’s disease worth of KRW 20 billion be open to the market?
The patent lawsuit of a Parkinson’s disease treatment recording KRW 20 billion annually has attracted attention of the pharmaceutical industry.
Stalevo(entacapone/carbidopa/levodopa) sold by Novartis is the most prescribed drug in dementia and parkinson’s disease along with Aricept.
Unlike othe...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
